ISPOR24 came to a completion yesterday and completely lived up to its reputation of being the top global event for Health Economics and Outcomes Research (HEOR) professionals. The event started with the first of its kind workshop focused “Patient-Centered Research Summit 2024”. Clinakos Inc. attended with other attendees from key institutions like FDA and PCORI, top pharmaceutical companies including AbbVie, Takeda, Gilead Sciences, patient advocacy groups and other stakeholders. We were proud to note that several speakers highlighted the importance of patient centered evidence generation, a field where we are considered a leading provider of unique patient data and technology solutions.
At this event and during the rest of the ISPOR conference, Clinakos received significant interest from current and new clients, researchers, advocacy groups and other partners, making this ISPOR our busiest ever. We also actively engaged in dialogues with potential collaborators and shared valuable perspectives.

The key highlights included:
🌟 Discussing the importance and use of Integrated Patient Data™ and Medically Smart AI™ for multiple use cases.
🌟Discussing the applications of the Clinakos approach especially in Rare Disease and Oncology projects.
🌟 Navigating the Evolving Landscape of Health Economic Evaluation in the Age of Generative AI
🌟 Unveiling Promising Approaches and Addressing Implementation Challenges in Global Differential Pricing
🌟 Bridging Divides and Cultivating Innovation Between Real-World Evidence (RWE) and HEOR Communities

As we look back on the invaluable insights generated and connections forged at the conference, we remain eager for further discourse. Should you wish to delve deeper into how Clinakos leverages our expertise for HEOR solutions, we stand ready to engage and offer comprehensive insights. Let’s continue the conversation and explore the impactful ways Clinakos is shaping the future of healthcare!